• Injury Law 101

  Overview

• Auto Accidents

  Overview Automobile Damage FAQ Insurance Coverage Seatbelt Issues Passenger Injuries Pedestrian Injuries Post-Accident FAQ Whiplash Speeding Speeding Data Fatality Charts Injury Data State Accident Chart

• Spinal Cord Injury

  Overview of SCI Effects of SCI Prevention Damages Links and Resources

• Traumatic Brain Injury

  Overview of TBI Proving TBI Indications of TBI Experts Involved TBI Data Links and Resources

• Wrongful Death

  Overview Damages for Death Common Defenses Workplace Death

• Insurance Bad Faith

  Overview Insurance Adjusters Links and Resources

• Airplane Accidents

  Overview Immediate Investigation Economy Class Syndrome Cause of Crash Data Common Carrier Liability Links and Resources

• Dog Bites

  Overview Prevention Data Links and Resources

• Drunk Drivers

  Overview FAQ Accident Data Alcohol Level Charts

• Large Truck Cases

  Overview Data

• Motorcycle Accidents

  Overview Accident Data Safety Tips

• School Bus Accidents

  Overview Data

• Slip and Fall

  Overview Property Owner Duty What To Do

• Unsafe Premises

  Overview

• Soc. Sec. Disability

  Overview

• Violent Crimes

  Overview

• Government Claims

  Overview

• Insurance Claims

  Overview

• On-The-Job Injuries

  Overview

• Railroad / Aviation

  Overview

• RSD Injuries

  Overview

• Dram Shop

  Overview

• Legal Malpractice

  Overview

• Passenger Claims

  Overview

• Products

  Tobacco Asbestos Firestone Tires Sulzer Hip Air Bags Zicam

• Drugs

  VIOXX Fen-Phen Propulsid Redux Duract Posicor Raxar PPA Pondimin Baycol Trasylol

• Supplements

  Ephedra Comfrey

• Sexual Assault

  Overview

• Business Disputes

  Overview

• DePuy Hip Replacement

  Overview

June 30, 2004 - New drug to prevent lasting brain damage

---

Pharmos is focused on helping people think more clearly -- with cannabis. The biotechnology company is developing cannabis-related compounds that don't have psychotropic effects as potential treatments for central nervous system disorders. Pharmos' lead drug candidate, dexanabinol, is a neuroprotective compound that could prevent lasting damage from traumatic brain injury. It has received FDA fast track status for this indication. The drug candidate may also limit post-surgery memory loss and cognitive impairment. Other targets for these compounds include stroke, neuropathic pain, multiple sclerosis, and Alzheimer's disease.